Cargando…
MPC-2 Clinical course and prognosis of lower-grade glioma, IDH wildtype and pTERT mutant
Background and Purpose: In the cIMPACT-Now update 3, it was proposed that grade 2 astrocytic gliomas without IDH-mutations and grade 3 astrocytic gliomas with TERT promoter mutations should be designated as diffuse IDH wildtype astrocytic glioma with molecular features of WHO grade IV glioblastoma....
Autores principales: | Takahashi, Yoshinobu, Takeuchi, Hayato, Tanigawa, Seisuke, Okamoto, Takanari, Hashimoto, Naoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648205/ http://dx.doi.org/10.1093/noajnl/vdab159.058 |
Ejemplares similares
-
MPC-1 DNA methylome analysis suggested the presence of “true” IDH-wildtype lower-grade gliomas
por: Satomi, Kaishi, et al.
Publicado: (2021) -
MPC-02 Prognostic effects of molecular factors in elderly patients with IDH-wildtype Glioblastomas
por: Fukai, Junya, et al.
Publicado: (2020) -
CBMS-1 Targeting amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas
por: Ohba, Shigeo, et al.
Publicado: (2021) -
Molecular landscape of
IDH
‐wild type, pTERT
‐wild type adult glioblastomas
por: Liu, Emma Munan, et al.
Publicado: (2022) -
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
por: Diplas, Bill H., et al.
Publicado: (2018)